Literature DB >> 22622342

Prevalence and associations of domestic violence at an Australian colposcopy clinic.

Julie A Quinlivan1, Rachael R Collier, Rodney W Petersen.   

Abstract

OBJECTIVE: Domestic violence is associated with significant mortality and morbidity including gynecological morbidity. We report the prevalence and associations of domestic violence in an Australian colposcopy service.
MATERIALS AND METHODS: A prospective study was performed from consecutive patients attending colposcopy clinics at a major metropolitan hospital in Australia. Key outcomes were the prevalence of intimate partner violence and its key demographic associations.
RESULTS: Consent was obtained from 574 and domestic violence status was ascertained in 566 of 581 women approached. Overall, 33% of responders reported violence within 12 months. In 14.5%, the female reported being sole recipient of violence; in a further 16.6%, violence was bidirectional, and in 1.9% of cases, a woman was the sole perpetrator. Key associations of violence were younger age at presentation (32 vs 35 y; p = .01), higher rates of smoking (51.3% vs 38.2%; p = .0004), higher rates of housing instability (32.2% vs 12.2%; p < .0001), a positive Beck Depression Inventory screen (50.0% vs 24.6%; p < .0001), and higher rates of default to initial attendance (15.5% vs 4.7%, p < .0001).
CONCLUSIONS: Domestic violence is common in women presenting to colposcopy services and may be associated with poor housing stability and higher default rates.

Entities:  

Mesh:

Year:  2012        PMID: 22622342     DOI: 10.1097/LGT.0b013e3182480c2e

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  1 in total

1.  Predictors of default from follow-up care in a cervical cancer screening program using direct visual inspection in south-western Nigeria.

Authors:  Oliver Chukwujekwu Ezechi; Karen Odberg Petterson; Titilola A Gbajabiamila; Ifeoma Eugenia Idigbe; Olutunmike Kuyoro; Innocent Achaya Otobo Ujah; Per Olof Ostergren
Journal:  BMC Health Serv Res       Date:  2014-03-31       Impact factor: 2.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.